Osteoporosis

Frequently Asked Questions

Join ALLEN!

(Session 2026 - 27)

Name

Mobile Number

Class

Choose class

Goal

Choose your goal

Preferred Programs

Preferred Mode

State

Choose State

I agree to

I authorise ALLEN Career Institute Pvt Ltd to send me regular updates via Phone calls, Whatsapp, SMS, Robocalls (Automated Calls), Emails, or on postal address.

Osteoporosis

Osteoporosis is a chronic skeletal disorder characterized by low bone mass and deterioration of bone tissue, leading to increased bone fragility and a higher risk of fractures—especially in the hip, spine, and wrist.

1.0Introduction

Bone performs three essential functions critical to maintaining overall health and mobility.
Firstly, it provides rigid structural support to the extremities and protects body cavities that house vital organs.
Secondly, bones act as efficient levers and serve as attachment sites for muscles, making them crucial for movement and locomotion.
Lastly, bones function as a major reservoir for vital minerals such as calcium, phosphorus, magnesium, and sodium.
These ions are essential for various physiological processes and can be mobilized when dietary intake is insufficient or when the body’s demand increases.

2.0Types of Bone

Cortical and Trabecular

Bone tissue is primarily categorized into cortical (compact) bone and trabecular (spongy) bone.
Cortical bone is dense and forms the outer layer of bones, particularly prominent in the shafts of long bones, where it is organized into Haversian systems to provide strength and rigidity.
In contrast, trabecular bone has a porous, lattice-like structure and is primarily found in the vertebrae and at the ends of long bones, where it contributes to lightness and shock absorption.
The distinct structural characteristics of these two types of bone lead to different patterns of bone loss, which in turn result in different fracture syndromes.

3.0Difference between Osteoblasts, Osteocytes and Osteoclasts

Osteoblasts	Osteocytes	Osteoclasts
Osteoblasts are the bone-forming cells that play an active role in synthesizing the bone matrix, primarily by producing collagen. Additionally, they are believed to assist in the transport of mineral ions between the extracellular fluid and the bone surface, contributing to bone mineralization.	They are thought to function as a cellular syncytium, enabling the transport of minerals into and out of deeper regions of bone that are not directly exposed to surfaces, while also facilitating intercellular signaling among bone cells.	These are the cells responsible for bone resorption, breaking down bone tissue to release minerals like calcium and phosphate into the bloodstream.

4.0Clinical Features

Osteoporosis often progresses silently and remains asymptomatic until a fracture occurs.
The earliest clinical sign is typically a wrist fracture or vertebral compression fracture, resulting from minimal trauma and causing intense, localized pain.
As the disease advances, repeated vertebral fractures may lead to chronic back pain. In cases of well-established osteoporosis, patients often experience dorsal kyphosis (a hunched back) and a noticeable loss of height.
Hip fractures are also common in severe osteoporosis and are frequently associated with serious, potentially fatal complications.
One such life-threatening outcome is pulmonary embolism, which may occur due to prolonged immobility during hospitalization following a fracture.

5.0Primary Osteoporosis

Type 1 Osteoporosis (Post Menopausal)

Type 2 Osteoporosis (Senile)

Fractures commonly occur in bones rich in trabecular (spongy) bone.

Typical examples include Colles’ fracture of the distal radius and compression or wedge fractures of the vertebrae. These types of fractures are more frequently seen in women, especially postmenopausal, due to decreased bone density.

Fractures involving bones that contain both cortical and trabecular components are also common.
A typical example is a fracture of the femoral neck in the hip, which frequently occurs in individuals over the age of 70. These fractures are often associated with significant morbidity and are a major concern in elderly populations due to reduced bone strength and balance issues.

Factors Associated with Decreased Bone Density

Medical Conditions

Premature menopause in women
Hypogonadism in men
Chronic liver disease
Hyperthyroidism
Hyperparathyroidism
Hemiplegia (paralysis of one side of the body)
Chronic obstructive pulmonary disease (COPD)

Drug-Related Causes

Long-term use of glucocorticoids
Anticonvulsant medications such as phenytoin and phenobarbitone

Nutritional Factors

Low dietary intake of calcium and vitamin D
Excessive intake of phosphorus (commonly found in carbonated drinks)
High consumption of protein, sodium, and caffeine

Behavioral and Lifestyle Factors

Smoking
Excessive alcohol consumption

6.0Treatment for Osteoporosis

Adolescents (During Peak Bone Mass Attainment, ~25–30 Years)

Calcium Intake: 1200 mg/day is recommended.
Vitamin D: Ensure adequate levels through direct sunlight exposure or supplementation.
Exercise: A moderate and regular physical activity routine is advised.

Premenopausal Women (Bone Mass Maintenance)

Calcium: 1000–1500 mg/day (note: excessive intake may lead to nephrocalcinosis).
Vitamin D: Maintain adequate levels through sunlight or supplements.
Exercise: Engage in regular weight-bearing and resistance exercises.
Lifestyle Modifications: Avoid conditions and factors that promote bone loss:
- Smoking, excessive caffeine and protein intake
- Amenorrhea or oligomenorrhea
- Long-term use of cortisone, loop diuretics, heparin, or excess thyroid hormone
- Hormonal imbalances (low estrogen/testosterone)

Immediately Postmenopausal Women (Preventing Bone Loss)

Hormone Replacement Therapy (HRT): Consider estrogen therapy:
- CEE 0.625 mg/day or transdermal patches (0.05–0.1 mg/day)
- If the uterus is intact, add medroxyprogesterone (5–10 mg daily)
Alternative Therapies:
- Bisphosphonates (e.g., Alendronate – 70 mg/week)
- SERMs (e.g., Raloxifene)
- Anabolic Hormones (e.g., PTH – not to be used >2 years due to osteosarcoma risk)

Elderly Women (>62 years) Without Fractures

Calcium: 1000–1500 mg/day
Vitamin D: Adequate supplementation
Exercise: Include paraspinal muscle strengthening under guidance
Avoid Risk Factors: Same as listed above
Treatment Options:
- HRT (if applicable)
- Bisphosphonates
- SERMs
- PTH (limited to 2 years)

Elderly Women (>62 years) With Fragility Fractures

Calcium: 1000–1500 mg/day
Vitamin D: Supplement as needed
Exercise: Gentle program with physiotherapy support
Supportive Measures: Consider non-rigid back bracing
Avoid Risk Factors: Same as above
Therapeutic Options:
- HRT
- Bisphosphonates
- SERMs
- PTH

Men With Low Bone Mass or Fractures

Calcium: 1000–1500 mg/day
Exercise & Bracing: Gentle strengthening and bracing if needed
Avoid Risk Factors: Same principles apply
Hormonal Therapy:
- Testosterone replacement if levels are low (consider prostate and lipid profile)
Additional Therapies:
- Bisphosphonates
- PTH (max 2 years)

Amenorrheic Females (e.g., due to excessive exercise or eating disorders)

General Measures: Reduce excessive exercise, restore body weight, and resume menstruation
Calcium: 1000–1500 mg/day
Other Therapies:
- Estrogen therapy
- Bisphosphonates

Steroid-Induced Osteopenia (Both Genders)

Bone Density Assessment: DEXA scan if available
Steroid Management: Use the lowest effective corticosteroid dose
Calcium and Vitamin D: 1000–1500 mg calcium with adequate vitamin D
Lifestyle & Therapy:
- Avoid osteopenia-promoting habits
- Consider hormonal therapy (estrogen for females, testosterone for males)
- Use bisphosphonates and PTH as needed

Frequently Asked Questions

Join ALLEN!

(Session 2026 - 27)

Name

Mobile Number

Class

Choose class

Goal

Choose your goal

Preferred Programs

Preferred Mode

State

Choose State

I agree to

I authorise ALLEN Career Institute Pvt Ltd to send me regular updates via Phone calls, Whatsapp, SMS, Robocalls (Automated Calls), Emails, or on postal address.

Osteoporosis

Osteoporosis is a chronic skeletal disorder characterized by low bone mass and deterioration of bone tissue, leading to increased bone fragility and a higher risk of fractures—especially in the hip, spine, and wrist.

1.0Introduction

Bone performs three essential functions critical to maintaining overall health and mobility.
Firstly, it provides rigid structural support to the extremities and protects body cavities that house vital organs.
Secondly, bones act as efficient levers and serve as attachment sites for muscles, making them crucial for movement and locomotion.
Lastly, bones function as a major reservoir for vital minerals such as calcium, phosphorus, magnesium, and sodium.
These ions are essential for various physiological processes and can be mobilized when dietary intake is insufficient or when the body’s demand increases.

2.0Types of Bone

Cortical and Trabecular

Bone tissue is primarily categorized into cortical (compact) bone and trabecular (spongy) bone.
Cortical bone is dense and forms the outer layer of bones, particularly prominent in the shafts of long bones, where it is organized into Haversian systems to provide strength and rigidity.
In contrast, trabecular bone has a porous, lattice-like structure and is primarily found in the vertebrae and at the ends of long bones, where it contributes to lightness and shock absorption.
The distinct structural characteristics of these two types of bone lead to different patterns of bone loss, which in turn result in different fracture syndromes.

3.0Difference between Osteoblasts, Osteocytes and Osteoclasts

Osteoblasts	Osteocytes	Osteoclasts
Osteoblasts are the bone-forming cells that play an active role in synthesizing the bone matrix, primarily by producing collagen. Additionally, they are believed to assist in the transport of mineral ions between the extracellular fluid and the bone surface, contributing to bone mineralization.	They are thought to function as a cellular syncytium, enabling the transport of minerals into and out of deeper regions of bone that are not directly exposed to surfaces, while also facilitating intercellular signaling among bone cells.	These are the cells responsible for bone resorption, breaking down bone tissue to release minerals like calcium and phosphate into the bloodstream.

4.0Clinical Features

Osteoporosis often progresses silently and remains asymptomatic until a fracture occurs.
The earliest clinical sign is typically a wrist fracture or vertebral compression fracture, resulting from minimal trauma and causing intense, localized pain.
As the disease advances, repeated vertebral fractures may lead to chronic back pain. In cases of well-established osteoporosis, patients often experience dorsal kyphosis (a hunched back) and a noticeable loss of height.
Hip fractures are also common in severe osteoporosis and are frequently associated with serious, potentially fatal complications.
One such life-threatening outcome is pulmonary embolism, which may occur due to prolonged immobility during hospitalization following a fracture.

5.0Primary Osteoporosis

Type 1 Osteoporosis (Post Menopausal)

Type 2 Osteoporosis (Senile)

Fractures commonly occur in bones rich in trabecular (spongy) bone.

Typical examples include Colles’ fracture of the distal radius and compression or wedge fractures of the vertebrae. These types of fractures are more frequently seen in women, especially postmenopausal, due to decreased bone density.

Fractures involving bones that contain both cortical and trabecular components are also common.
A typical example is a fracture of the femoral neck in the hip, which frequently occurs in individuals over the age of 70. These fractures are often associated with significant morbidity and are a major concern in elderly populations due to reduced bone strength and balance issues.

Factors Associated with Decreased Bone Density

Medical Conditions

Premature menopause in women
Hypogonadism in men
Chronic liver disease
Hyperthyroidism
Hyperparathyroidism
Hemiplegia (paralysis of one side of the body)
Chronic obstructive pulmonary disease (COPD)

Drug-Related Causes

Long-term use of glucocorticoids
Anticonvulsant medications such as phenytoin and phenobarbitone

Nutritional Factors

Low dietary intake of calcium and vitamin D
Excessive intake of phosphorus (commonly found in carbonated drinks)
High consumption of protein, sodium, and caffeine

Behavioral and Lifestyle Factors

Smoking
Excessive alcohol consumption

6.0Treatment for Osteoporosis

Adolescents (During Peak Bone Mass Attainment, ~25–30 Years)

Calcium Intake: 1200 mg/day is recommended.
Vitamin D: Ensure adequate levels through direct sunlight exposure or supplementation.
Exercise: A moderate and regular physical activity routine is advised.

Premenopausal Women (Bone Mass Maintenance)

Calcium: 1000–1500 mg/day (note: excessive intake may lead to nephrocalcinosis).
Vitamin D: Maintain adequate levels through sunlight or supplements.
Exercise: Engage in regular weight-bearing and resistance exercises.
Lifestyle Modifications: Avoid conditions and factors that promote bone loss:
- Smoking, excessive caffeine and protein intake
- Amenorrhea or oligomenorrhea
- Long-term use of cortisone, loop diuretics, heparin, or excess thyroid hormone
- Hormonal imbalances (low estrogen/testosterone)

Immediately Postmenopausal Women (Preventing Bone Loss)

Hormone Replacement Therapy (HRT): Consider estrogen therapy:
- CEE 0.625 mg/day or transdermal patches (0.05–0.1 mg/day)
- If the uterus is intact, add medroxyprogesterone (5–10 mg daily)
Alternative Therapies:
- Bisphosphonates (e.g., Alendronate – 70 mg/week)
- SERMs (e.g., Raloxifene)
- Anabolic Hormones (e.g., PTH – not to be used >2 years due to osteosarcoma risk)

Elderly Women (>62 years) Without Fractures

Calcium: 1000–1500 mg/day
Vitamin D: Adequate supplementation
Exercise: Include paraspinal muscle strengthening under guidance
Avoid Risk Factors: Same as listed above
Treatment Options:
- HRT (if applicable)
- Bisphosphonates
- SERMs
- PTH (limited to 2 years)

Elderly Women (>62 years) With Fragility Fractures

Calcium: 1000–1500 mg/day
Vitamin D: Supplement as needed
Exercise: Gentle program with physiotherapy support
Supportive Measures: Consider non-rigid back bracing
Avoid Risk Factors: Same as above
Therapeutic Options:
- HRT
- Bisphosphonates
- SERMs
- PTH

Men With Low Bone Mass or Fractures

Calcium: 1000–1500 mg/day
Exercise & Bracing: Gentle strengthening and bracing if needed
Avoid Risk Factors: Same principles apply
Hormonal Therapy:
- Testosterone replacement if levels are low (consider prostate and lipid profile)
Additional Therapies:
- Bisphosphonates
- PTH (max 2 years)

Amenorrheic Females (e.g., due to excessive exercise or eating disorders)

General Measures: Reduce excessive exercise, restore body weight, and resume menstruation
Calcium: 1000–1500 mg/day
Other Therapies:
- Estrogen therapy
- Bisphosphonates

Steroid-Induced Osteopenia (Both Genders)

Bone Density Assessment: DEXA scan if available
Steroid Management: Use the lowest effective corticosteroid dose
Calcium and Vitamin D: 1000–1500 mg calcium with adequate vitamin D
Lifestyle & Therapy:
- Avoid osteopenia-promoting habits
- Consider hormonal therapy (estrogen for females, testosterone for males)
- Use bisphosphonates and PTH as needed

Frequently Asked Questions

What causes osteoporosis?

Who is most at risk for developing osteoporosis?

Can osteoporosis be prevented?

What is the treatment for osteoporosis?

Can men get osteoporosis?

Join ALLEN!

Osteoporosis

1.0Introduction

2.0Types of Bone

3.0Difference between Osteoblasts, Osteocytes and Osteoclasts

4.0Clinical Features

5.0Primary Osteoporosis

Factors Associated with Decreased Bone Density

6.0Treatment for Osteoporosis

Table of Contents

Frequently Asked Questions

What causes osteoporosis?

Who is most at risk for developing osteoporosis?

Can osteoporosis be prevented?

What is the treatment for osteoporosis?

Can men get osteoporosis?

Join ALLEN!

Osteoporosis

1.0Introduction

2.0Types of Bone

3.0Difference between Osteoblasts, Osteocytes and Osteoclasts

4.0Clinical Features

5.0Primary Osteoporosis

Factors Associated with Decreased Bone Density

6.0Treatment for Osteoporosis

Table of Contents